Home > Boards > US Listed > Medical - Drugs > Humanigen Inc. (HGEN)

POTUS ARDS -$HGEN Lenzilumab is last line of

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Fezziwig2008 Member Profile
 
Followed By 26
Posts 501
Boards Moderated 1
Alias Born 03/09/14
160x600 placeholder
アジア太平洋地域での成長計画を促進すべくHumanigen Australia Proprietary Limitedを設立 Business Wire - 11/25/2020 11:01:00 AM
Humanigen Australia Proprietary Limited Established to Facilitate Asia-Pacific Growth Plans Business Wire - 11/23/2020 4:05:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 11/20/2020 6:04:41 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/12/2020 4:17:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2020 6:07:48 AM
Humanigen Reports Third Quarter and Nine Months Ended September 30, 2020 Financial Results Business Wire - 11/11/2020 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2020 4:54:34 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/6/2020 9:14:09 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2020 9:06:44 AM
Humanigen Announces Positive Interim Phase 3 Data of Lenzilumab™ in Patients Hospitalized with COVID-19 Business Wire - 11/6/2020 7:00:00 AM
Humanigen Announces Cooperative Research & Development Agreement with the Department of Defense to Develop Lenzilumab for COV... Business Wire - 11/6/2020 7:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/4/2020 5:01:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2020 4:46:15 PM
Humanigen Announces ZUMA-19 Abstract Accepted for Presentation at American Society of Hematology 2020 Annual Meeting Business Wire - 11/4/2020 4:05:00 PM
Humanigen Executes Licensing Agreement for Lenzilumab™ in COVID-19 with KPM Tech/Telcon RF Pharmaceutical for South Korea &... Business Wire - 11/3/2020 7:30:00 AM
Humanigen Announces First Patient Dosed at MedStar Washington Hospital Center in Phase 3 Clinical Study of Lenzilumab in COVI... Business Wire - 10/30/2020 2:05:00 PM
Humanigen Announces First Patient Dosed in NIH ACTIV-5/Big Effect Trial Evaluating Lenzilumab™ for COVID-19 Business Wire - 10/29/2020 7:00:00 AM
Humanigen to Present at Upcoming Investor Conferences Business Wire - 10/27/2020 4:01:00 PM
National Institutes of Health Launches its ACTIV-5 “Big Effect Trial” Evaluating Humanigen’s Lenzilumab™ as Potential... Business Wire - 10/13/2020 11:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/7/2020 4:31:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/7/2020 4:30:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2020 4:14:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2020 4:08:22 PM
Humanigen Announces COVID-19 Case Report Demonstrating Rapid Resolution & Discharge after Single IND Emergency Use Authorizat... Business Wire - 10/2/2020 8:00:00 AM
Humanigen Announces Lenzilumab in COVID-19 Program Updates Business Wire - 10/2/2020 7:00:00 AM
Fezziwig2008   Monday, 10/05/20 08:17:32 AM
Re: None
Post # of 22133 
POTUS ARDS -$HGEN Lenzilumab is last line of Defense! From NYT Now- “Based on the doctors’ account, Mr. Trump’s symptoms appear to have rapidly progressed since he announced early Friday morning that he had tested positive for the coronavirus.

Mr. Trump had a “high fever” on Friday, and there were two occasions when his blood oxygen levels dropped, his doctors said — on Friday and again on Saturday. The president’s oxygen saturation level was 93 percent at one point, his doctors said, below the 95 percent that is considered the lower limit of the normal range.”

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences